Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts
Ribozymes are a promising agent for the gene therapy of dominant negative genetic disorders by allele-specific mRNA suppression. To test allele-specific mRNA suppression in cells, we used fibroblasts from a patient with osteogenesis imperfecta (OI). These cells contain a mutation in one α1(I) collag...
保存先:
| 出版年: | Nucleic Acids Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2000
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC110781/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11024182/ https://ncbi.nlm.nih.govhttps://doi.org/10.1093/nar/28.20.4013 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|